• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌和肺结核患者胸腔积液的外泌体微小RNA谱分析

Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.

作者信息

Zhang Xuede, Bao Lingling, Yu Guohua, Wang Haifeng

机构信息

Department of Oncology, Weifang People's Hospital, Weifang, China.

Department of Hematology and Oncology, Beilun District People's Hospital, Ningbo, China.

出版信息

Front Surg. 2023 Jan 6;9:1050242. doi: 10.3389/fsurg.2022.1050242. eCollection 2022.

DOI:10.3389/fsurg.2022.1050242
PMID:36684253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9852630/
Abstract

BACKGROUND

Pleural effusion (PE) caused by lung cancer is prevalent, and it is difficult to differentiate it from PE caused by tuberculosis. Exosome-based liquid biopsy offers a non-invasive technique to diagnose benign and malignant PE. Exosomal miRNAs are potential diagnostic markers and play an essential role in signal transduction and biological processes in tumor development. We hypothesized that exosomal miRNA expression profiles in PE would contribute to identifying its diagnostic markers and elucidating the molecular basis of PE formation in lung cancer.

METHODS

The exosomes from PE caused by lung adenocarcinoma (LUAD) and pulmonary tuberculosis were isolated and verified by transmission electron microscopy. The exosomal miRNA profiles were identified using deep sequencing and validated with quantitative real-time PCR (qRT-PCR). We performed bioinformatic analysis for differentially expressed miRNAs to explore how exosomal miRNAs regulate pleural effusion.

RESULTS

We identified 99 upregulated and 91 downregulated miRNAs in malignant pleural effusion (MPE) compared to tuberculous pleural effusion (TPE). Seven differentially expressed miRNAs (DEmiRNAs) were validated by qRT-PCR, out of which 5 (71.4%) were confirmed through sequencing. Gene Ontology (GO) analysis revealed that most exosomal miRNAs target genes were involved in regulating cellular processes and nitrogen compound metabolism. According to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, the exosomal miRNAs target genes were mainly involved in Fc gamma R-mediated phagocytosis, Rap1 signaling pathway, and breast cancer. The hub genes, including ITGAM, FOXO1, MAPK14, YWHAB, GRIN1, and PRF1, were screened through plug-in cytoHubba. The PFR1 was identified as a critical gene in MPE formation using single-cell sequencing analysis. Additionally, we hypothesized that tumor cells affected natural killer cells and promoted the generation of PE in LUAD the exosomal hsa-miR-3120-5p-PRF1 axis.

CONCLUSIONS

We identified exosomal miRNA profiles in LUAD-MPE and TPE, which may help in the differential diagnosis of MPE and TPE. Bioinformatic analysis revealed that these miRNAs might affect PE generation through tumor immune response in LUAD. Our results provided a new theoretical basis for understanding the function of exosomal miRNAs in LUAD-MPE.

摘要

背景

肺癌所致胸腔积液(PE)较为常见,且难以与结核性胸腔积液相鉴别。基于外泌体的液体活检提供了一种非侵入性技术用于诊断良性和恶性胸腔积液。外泌体微小RNA(miRNA)是潜在的诊断标志物,在肿瘤发生发展的信号转导和生物学过程中发挥重要作用。我们推测,胸腔积液中外泌体miRNA表达谱有助于识别其诊断标志物并阐明肺癌中胸腔积液形成的分子基础。

方法

分离并通过透射电子显微镜验证了肺腺癌(LUAD)和肺结核所致胸腔积液中的外泌体。使用深度测序鉴定外泌体miRNA谱,并通过定量实时聚合酶链反应(qRT-PCR)进行验证。我们对差异表达的miRNA进行生物信息学分析,以探讨外泌体miRNA如何调节胸腔积液。

结果

与结核性胸腔积液(TPE)相比,我们在恶性胸腔积液(MPE)中鉴定出99个上调的miRNA和91个下调的miRNA。通过qRT-PCR验证了7个差异表达的miRNA(DEmiRNAs),其中5个(71.4%)通过测序得到确认。基因本体(GO)分析显示,大多数外泌体miRNA靶基因参与调节细胞过程和氮化合物代谢。根据京都基因与基因组百科全书(KEGG)通路富集分析,外泌体miRNA靶基因主要参与FcγR介导的吞噬作用、Rap1信号通路和乳腺癌。通过插件cytoHubba筛选出包括整合素αM(ITGAM)、叉头框蛋白O1(FOXO1)、丝裂原活化蛋白激酶14(MAPK14)、14-3-3蛋白β/α(YWHAB)、谷氨酸离子型受体NMDA 1型亚基(GRIN1)和穿孔素1(PRF1)在内的枢纽基因。通过单细胞测序分析确定PFR1是MPE形成中的关键基因。此外,我们推测肿瘤细胞影响自然杀伤细胞并通过外泌体hsa-miR-3120-5p-PRF1轴促进LUAD中胸腔积液的产生。

结论

我们鉴定了LUAD-MPE和TPE中的外泌体miRNA谱,这可能有助于MPE和TPE的鉴别诊断。生物信息学分析表明,这些miRNA可能通过LUAD中的肿瘤免疫反应影响胸腔积液的产生。我们的结果为理解外泌体miRNA在LUAD-MPE中的功能提供了新的理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/fb74de66fb64/fsurg-09-1050242-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/6db69cacc45f/fsurg-09-1050242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/c9b2c3e32caf/fsurg-09-1050242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/00b3e17312eb/fsurg-09-1050242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/8b8e5b4751e9/fsurg-09-1050242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/99502a845f3a/fsurg-09-1050242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/fb74de66fb64/fsurg-09-1050242-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/6db69cacc45f/fsurg-09-1050242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/c9b2c3e32caf/fsurg-09-1050242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/00b3e17312eb/fsurg-09-1050242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/8b8e5b4751e9/fsurg-09-1050242-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/99502a845f3a/fsurg-09-1050242-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8af9/9852630/fb74de66fb64/fsurg-09-1050242-g006.jpg

相似文献

1
Exosomal miRNA-profiling of pleural effusion in lung adenocarcinoma and tuberculosis.肺腺癌和肺结核患者胸腔积液的外泌体微小RNA谱分析
Front Surg. 2023 Jan 6;9:1050242. doi: 10.3389/fsurg.2022.1050242. eCollection 2022.
2
Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.生物信息学分析与实验验证相结合,鉴定出血浆外泌体 miR-103b/877-5p/29c-5p 作为早期肺腺癌的诊断生物标志物。
Cancer Med. 2022 Dec;11(23):4411-4421. doi: 10.1002/cam4.4788. Epub 2022 May 18.
3
Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma.构建并分析肺腺癌胸腔积液外泌体 lncRNAs 的表达谱。
J Clin Lab Anal. 2022 Dec;36(12):e24777. doi: 10.1002/jcla.24777. Epub 2022 Nov 25.
4
Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions.肺腺癌、肺结核及其他良性病变中差异表达的PE外泌体miRNA的鉴定
Medicine (Baltimore). 2017 Nov;96(44):e8361. doi: 10.1097/MD.0000000000008361.
5
Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.鉴别良、恶性胸腔积液中差异表达的 microRNAs。
Hereditas. 2020 Feb 26;157(1):6. doi: 10.1186/s41065-020-00119-z.
6
Tuberculous Pleural Effusion-Derived Exosomal miR-130b-3p and miR-423-5p Promote the Proliferation of Lung Cancer Cells via Cyclin D1.结核性胸腔积液衍生的外泌体 miR-130b-3p 和 miR-423-5p 通过细胞周期蛋白 D1 促进肺癌细胞的增殖。
Int J Mol Sci. 2024 Sep 20;25(18):10119. doi: 10.3390/ijms251810119.
7
Extracellular Vesicle MicroRNA in Malignant Pleural Effusion.恶性胸腔积液中的细胞外囊泡 microRNA。
Genes (Basel). 2022 Nov 19;13(11):2159. doi: 10.3390/genes13112159.
8
Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.恶性胸腔积液中 microRNA 表达谱及环状 RNA 调控网络分析。
Cell Cycle. 2018;17(24):2819-2832. doi: 10.1080/15384101.2018.1558860. Epub 2018 Dec 27.
9
Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.评估血清和胸腔积液中的一组 microRNA 用于良恶性胸腔积液的鉴别诊断。
Cancer Biomark. 2022;33(1):71-82. doi: 10.3233/CBM-210090.
10
Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.定量蛋白质组学揭示了可区分恶性胸腔积液和良性胸腔积液的蛋白质生物标志物。
J Proteomics. 2024 Jun 30;302:105201. doi: 10.1016/j.jprot.2024.105201. Epub 2024 May 18.

引用本文的文献

1
Exosomal miR-182-5p is a potential diagnostic marker for malignant pleural effusion.外泌体miR-182-5p是恶性胸腔积液的一种潜在诊断标志物。
Transl Lung Cancer Res. 2025 Apr 30;14(4):1138-1148. doi: 10.21037/tlcr-2024-1205. Epub 2025 Apr 16.
2
Exosome-Derived miRNAs in Liquid Biopsy for Lung Cancer.液体活检中用于肺癌检测的外泌体衍生微小RNA
Life (Basel). 2024 Dec 4;14(12):1608. doi: 10.3390/life14121608.
3
Lung cancer cell-derived exosomes: progress on pivotal role and its application in diagnostic and therapeutic potential.

本文引用的文献

1
Distinct Gene Set Enrichment Profiles in Eosinophilic and Non-Eosinophilic Chronic Rhinosinusitis with Nasal Polyps by Bulk RNA Barcoding and Sequencing.基于批量 RNA 条码和测序的嗜酸粒细胞性和非嗜酸粒细胞性慢性鼻-鼻窦炎伴鼻息肉的独特基因集富集图谱。
Int J Mol Sci. 2022 May 18;23(10):5653. doi: 10.3390/ijms23105653.
2
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.膀胱癌患者生存时间估计的 microRNA 特征。
Sci Rep. 2022 Mar 9;12(1):4141. doi: 10.1038/s41598-022-08082-7.
3
LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma.
肺癌细胞衍生的外泌体:关键作用及其在诊断和治疗潜力方面的进展
Front Oncol. 2024 Oct 11;14:1459178. doi: 10.3389/fonc.2024.1459178. eCollection 2024.
4
The role of exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers.外泌体微小RNA在宿主-病原体相互作用中作为诊断和治疗生物标志物的作用。
Front Microbiol. 2024 Aug 8;15:1441781. doi: 10.3389/fmicb.2024.1441781. eCollection 2024.
5
Bladder Cancer in Exosomal Perspective: Unraveling New Regulatory Mechanisms.外泌体视角下的膀胱癌:揭开新的调控机制。
Int J Nanomedicine. 2024 Apr 22;19:3677-3695. doi: 10.2147/IJN.S458397. eCollection 2024.
6
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.超越血液:在肿瘤学和个性化医学中推进液体活检的前沿。
Cancer Sci. 2024 Apr;115(4):1060-1072. doi: 10.1111/cas.16097. Epub 2024 Feb 3.
7
Cargoes of exosomes function as potential biomarkers for infection.外泌体携带的货物可作为感染的潜在生物标志物。
Front Immunol. 2023 Oct 18;14:1254347. doi: 10.3389/fimmu.2023.1254347. eCollection 2023.
8
SOX9 promotes the invasion and migration of lung adenocarcinoma cells by activating the RAP1 signaling pathway.SOX9 通过激活 RAP1 信号通路促进肺腺癌细胞的侵袭和迁移。
BMC Pulm Med. 2023 Nov 2;23(1):421. doi: 10.1186/s12890-023-02740-w.
9
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications.肺癌中的非编码RNA:分子机制与临床应用
Front Oncol. 2023 Sep 8;13:1256537. doi: 10.3389/fonc.2023.1256537. eCollection 2023.
LiKidMiRs:用于检测肾细胞癌的基于数字PCR的4种循环微RNA检测组
Cancers (Basel). 2022 Feb 9;14(4):858. doi: 10.3390/cancers14040858.
4
MicroRNA expression integrated analysis and identification of novel biomarkers in small cell lung cancer: a meta-analysis.小细胞肺癌中MicroRNA表达的综合分析及新型生物标志物的鉴定:一项荟萃分析
Transl Cancer Res. 2020 May;9(5):3339-3353. doi: 10.21037/tcr.2020.04.12.
5
TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.TYROBP、TLR4 和 ITGAM 调节骨肉瘤中巨噬细胞的极化和免疫检查点表达。
Sci Rep. 2021 Sep 29;11(1):19315. doi: 10.1038/s41598-021-98637-x.
6
Histiocytic pleural effusion: the strong clue to malignancy.组织细胞性胸腔积液:恶性肿瘤的有力线索。
World J Surg Oncol. 2021 Jun 16;19(1):180. doi: 10.1186/s12957-021-02296-1.
7
Diagnostic utility of pleural fluid carcinoembryonic antigen in patients with exudative pleural effusion.癌胚抗原在渗出性胸腔积液患者胸腔积液中的诊断价值
Lung India. 2021 Mar-Apr;38(2):139-143. doi: 10.4103/lungindia.lungindia_196_20.
8
Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6.环状 RNA circ_103820 通过海绵吸附 miR-200b-3p 释放 LATS2 和 SOCS6 来抑制肺癌肿瘤发生。
Cell Death Dis. 2021 Feb 15;12(2):185. doi: 10.1038/s41419-021-03472-7.
9
Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy.基于外泌体检测前瞻性入组的非小细胞肺癌患者一线酪氨酸激酶抑制剂治疗后血浆和胸腔积液中的表皮生长因子受体(EGFR)T790M
Cancer Cell Int. 2021 Jan 12;21(1):50. doi: 10.1186/s12935-021-01761-x.
10
Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients.评估患者血浆中的 ZNF154 甲基化作为结直肠癌、肝癌、卵巢癌和胰腺癌患者液体活检中的多癌种标志物。
Sci Rep. 2021 Jan 8;11(1):221. doi: 10.1038/s41598-020-80345-7.